Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel PACS1 Variant Associated With Schuurs-Hoeijmakers Syndrome Phenotype in an Indigenous Descendant in Brazil: A Case Report. | Cureus | 2022 | 36415352 | PubTator, text mining | PubMed |
| A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer. | Front Oncol | 2022 | 36408135 | PubTator, text mining | PubMed |
| Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas. | Front Mol Neurosci | 2022 | 36407768 | PubTator, text mining | PubMed |
A 6-Day-Old Male Infant with Severe Hyperbilirubinemia Diagnosed with Hereditary Spherocytosis at a Tertiary Hospital in East Java, Indonesia: A Diagnostic and Management Challenge in a Developing Country. | Am J Case Rep | 2022 | 36399434 | PubTator, text mining | PubMed |
| Genome-wide metabolite quantitative trait loci analysis (mQTL) in red blood cells from volunteer blood donors. | J Biol Chem | 2022 | 36395887 | PubTator, text mining | PubMed |
| Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients. | Front Immunol | 2022 | 36389681 | PubTator, text mining | PubMed |
| Construction and Validation of Early Warning Model of Lung Cancer Based on Machine Learning: A Retrospective Study. | Technol Cancer Res Treat | 2022 | 36380607 | PubTator, text mining | PubMed |
| A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice. | BMC Cancer | 2022 | 36376839 | PubTator, text mining | PubMed |
| The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36358602 | PubTator, text mining | PubMed |
| Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy. | Cancer Commun (Lond) | 2022 | 36331328 | PubTator, text mining | PubMed |
| A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer. | Front Immunol | 2022 | 36325340 | PubTator, text mining | PubMed |
| Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma. | Front Genet | 2022 | 36313439 | PubTator, text mining | PubMed |
| m6A/ m1A /m5C/m7G-related methylation modification patterns and immune characterization in prostate cancer. | Front Pharmacol | 2022 | 36313300 | PubTator, text mining | PubMed |
| Integrative genomic analysis facilitates precision strategies for glioblastoma treatment. | iScience | 2022 | 36300002 | PubTator, text mining | PubMed |
| Bioinformatics Analysis Identifies TNFRSF1A as a Biomarker of Liver Injury in Sepsis TNFRSF1A is a Biomarker for Septic Liver Injury. | Genet Res (Camb) | 2022 | 36299685 | PubTator, text mining | PubMed |
| Tight Junctions, the Key Factor in Virus-Related Disease. | Pathogens | 2022 | 36297257 | PubTator, text mining | PubMed |
| Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis. | Hematol Rep | 2022 | 36278520 | PubTator, text mining | PubMed |
| A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer. | Front Genet | 2022 | 36276952 | PubTator, text mining | PubMed |
| From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. | Int J Chron Obstruct Pulmon Dis | 2022 | 36274992 | PubTator, text mining | PubMed |
| Filamentous fungal biofilms: Conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus. | NPJ Biofilms Microbiomes | 2022 | 36261442 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=16